We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · October 05, 2021

Echocardiographic Assessment of Myocardial Dysfunction for Arrhythmic Risk Stratification in PLN Mutation Carriers

European Heart Journal Cardiovascular Imaging

 

Additional Info

European Heart Journal Cardiovascular Imaging
Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriers
Eur Heart J Cardiovasc Imaging 2021 Sep 13;[EPub Ahead of Print], K Taha, TE Verstraelen, R de Brouwer, RHACM de Bruin-Bon, MJ Cramer, WP Te Rijdt, BJ Bouma, RA de Boer, PA Doevendans, FW Asselbergs, AAM Wilde, MP van den Berg, AJ Teske

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading